Filing Details
- Accession Number:
- 0001209191-18-018856
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-12 16:12:43
- Reporting Period:
- 2018-03-08
- Accepted Time:
- 2018-03-12 16:12:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 917520 | Integra Lifesciences Holdings Corp | IART | Laboratory Analytical Instruments (3826) | 510317849 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1187576 | E Richard Caruso | 795 E Lancaster Avenue, Suite 200 Villanova PA 19085 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-08 | 12,002 | $18.06 | 146,136 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-03-08 | 12,002 | $53.68 | 134,134 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-03-08 | 20,878 | $18.06 | 155,012 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-03-08 | 20,878 | $53.68 | 134,134 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-03-08 | 12,002 | $0.00 | 12,002 | $18.06 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-03-08 | 20,878 | $0.00 | 20,878 | $18.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-05-19 | No | 4 | M | Direct | |
| 0 | 2018-05-19 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 46,676 | Indirect | By Corporation |
| Common Stock | 11,982,410 | Indirect | By Partnership |
| Common Stock | 4,000 | Indirect | By Son |
Footnotes
- On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $53.37 to $54.
- 25% of the stock options vest every quarter from the grant date of 5/19/2010
- This option was previously reported as covering 5,749 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 6,001 shares of common stock at an exercise price of $36.12 per share.
- In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
- This option was previously reported as covering 10,000 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 10,439 shares of common stock at an exercise price of $36.12 per share.
Billionaire Hedge Funds
